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Abstract The deep-sea shrimp Oplophorus gracilirostris se-
cretes a luciferase that catalyzes the oxidation of coelenterazine
to emit blue light. The luciferase (Mr approx. 106 000) was found
to be a complex composed of 35 kDa and 19 kDa proteins, and
the cDNAs encoding these two proteins were cloned. The
expression of the cDNAs in bacterial and mammalian cells
indicated that the 19 kDa protein, not the 35 kDa protein, is
capable of catalyzing the luminescent oxidation of coelenter-
azine. The primary sequence of the 35 kDa protein revealed a
typical leucine-rich repeat sequence, whereas the catalytic 19
kDa protein shared no homology with any known luciferases
including various imidazopyrazinone luciferases. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
The deep-sea shrimp Oplophorus gracilirostris (H. Milne-
Edwards, 1881) ejects a blue luminous cloud from the base
of its antennae when stimulated [1^3], like various other lu-
minescent decapod shrimps including those of the genera He-
terocarpus, Systellaspis and Acanthephyra [4]. The mechanism
underlying the luminescence of Oplophorus involves the oxi-
dation of Oplophorus luciferin (coelenterazine) with molecular
oxygen, which is catalyzed by Oplophorus luciferase [2,3] as
follows:
CoelenterazineO2 ÿ!Oplophorus luciferaseCoelenteramide 
CO2  he V max  454 nm
It is well known that coelenterazine, an imidazopyrazinone
compound, is involved in the bioluminescence of a wide vari-
ety of organisms as a luciferin or as the functional moiety of
photoproteins. For example, the luciferin of the sea pansy
Renilla is coelenterazine [5], and the calcium-sensitive photo-
protein aequorin from the jelly¢sh Aequorea also contains
coelenterazine as its functional moiety [6,7].
The previous studies of Oplophorus luciferase reported in
1978 [3] showed various interesting properties of this enzyme,
such as a high speci¢c activity (1.75U1015 photons/s mg at
23‡C), a high quantum yield (0.34 at 22‡C) and optimum light
emission at a high temperature (40‡C). Recently, it has been
found that the substrate speci¢city of Oplophorus luciferase is
unexpectedly broad [8], revealing that bisdeoxycoelenterazine,
an analogue of coelenterazine, is an excellent substrate com-
parable to coelenterazine [9]. Moreover, Oplophorus luciferase
is a secreted enzyme like the luciferase of the marine ostracod
Cypridina (Vargula) hilgendor¢i [10] which also uses an imid-
azopyrazinone-type luciferin to emit light. Some of these
properties of Oplophorus luciferase clearly distinguish this en-
zyme from Renilla luciferase and aequorin. On the other
hand, a luciferase functioning with an imidazopyrazinone-
type substrate, such as that of Oplophorus or Cypridina, would
be more favorable for use as a reporter than the luciferase of
¢re£y or luminous bacteria, which requires co-factors in ad-
dition to luciferin in the luminescence reaction. The simplicity
of the system, combined with the high sensitivity, may make
the luciferase of Oplophorus a highly useful reporter.
Previously, the molecular weight of Oplophorus luciferase
was reported to be 130 kDa (by gel ¢ltration) for the native
protein, and 31 kDa after treatment with SDS [3]. In our
recent study, the luciferase showed a molecular weight of ap-
proximately 106 kDa in gel ¢ltration, and we found that the
molecule breaks down into 35 kDa and 19 kDa proteins upon
sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) analysis. The present paper reports the molec-
ular cloning of the cDNAs encoding the 35 kDa and 19 kDa
proteins, and the identi¢cation of the protein component that
catalyzes the luminescence reaction.
2. Materials and methods
2.1. Puri¢cation and amino acid sequence analysis of native Oplophorus
luciferase
A puri¢ed preparation of Oplophorus luciferase obtained in 1978 [3]
was further puri¢ed by two steps of chromatography. The ¢rst step
was by hydrophobic interaction chromatography on a column of bu-
tyl Sepharose 4 Fast Flow (Pharmacia; 0.7U3.5 cm) using 20 mM
Tris^HCl, pH 8.5, eluting with decreasing concentrations of ammo-
nium sulfate starting at 1.5 M. The second step was by gel ¢ltration
on a column of Superdex 200 Prep (Pharmacia; 1U48 cm) in 20 mM
Tris^HCl, pH 8.0, containing 50 mM NaCl. The speci¢c activity of
the puri¢ed luciferase was 1.3U1015 quanta/s mg, which was slightly
lower than the value obtained in 1978 but the protein purity was
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 9 6 3 - 3
*Corresponding author. Fax: (81)-45-786 5512.
E-mail: sinouye@chisso.co.jp
1 This paper is dedicated to the late Professor Kazuhiko Umesono
(deceased 12 April 1999).
Abbreviations: CMV, cytomegalovirus; HPLC, high performance liq-
uid chromatography; PCR, polymerase chain reaction; SDS^PAGE,
sodium dodecyl sulfate^polyacrylamide gel electrophoresis
FEBS 24076 1-9-00
FEBS 24076 FEBS Letters 481 (2000) 19^25
clearly higher. A solution of puri¢ed luciferase (25 Wg protein in
0.3 ml) dissolved in 0.1% SDS was subjected to high performance
liquid chromatography (HPLC) on a gel ¢ltration column, TSK
3000SW (Toso; 0.75U30 cm), using 20 mM Tris^HCl, pH 7.7, con-
taining 0.1 M NaCl and 0.1% SDS. The elution pro¢le monitored at
280 nm showed two major components, 35 kDa and 19 kDa proteins,
and the results were con¢rmed by SDS^PAGE analysis (12% gel;
Tefco, Tokyo, Japan) under reducing conditions [11]. The two protein
bands separated by SDS^PAGE were transferred electrophoretically
onto a polyvinylidene di£uoride membrane (Millipore, Bedford, MA,
USA) [12], and the proteins were subjected to amino acid sequence
analysis on an Applied Biosystems model 470A gas phase sequencer.
The 35 kDa protein was also obtained from the native luciferase
(50 Wg) by reversed phase HPLC on a 5C4 column (Waters;
0.39U15 cm; solvent: acetonitrile/water/0.1% tri£uoroacetic acid).
The protein was then digested with lysyl endopeptidase (Boehringer;
sequencing grade) at an enzyme:substrate ratio of 1:50. The peptide
fragments obtained were separated by reversed phase HPLC on a 5C8
column (Vydac; 0.46U25 cm) by gradient elution with increasing
concentrations of acetonitrile (15^55% in 80 min; £ow rate
0.5 ml/min) in the presence of 0.1% tri£uoroacetic acid, monitoring
at 220 nm.
2.2. mRNA preparation and cDNA library construction
Two specimens of O. gracilirostris (body size: 40 mm long) were
obtained on board in Suruga Bay, Japan, on 19 November 1997, by
selecting this species from a catch of the Sakura-ebi (Sergestes sp.)
shrimp. The live specimens were frozen on dry ice and stored at
380‡C until used. Total RNA was prepared by the guanidine isothio-
cyanate method [13,14], followed by precipitation with 2 M LiCl. The
yield of total RNA from two whole specimens (2.8 g wet weight) was
approximately 0.9 mg. Poly(A) RNA (2 Wg) isolated by oligo(dT)-
cellulose spun column (Pharmacia, Piscataway, NJ, USA) was used in
the synthesis of cDNA with dT12ÿ18 primers using a cDNA synthesis
kit (Pharmacia) [15]. cDNAs containing EcoRI/NotI linker sites
(20 ng) were ligated to 1 Wg of EcoRI digested/calf intestinal alkaline
phosphatase-treated VZapII vector (Stratagene, La Jolla, CA, USA),
then packaged in vitro using a Gigapack Gold III packaging kit
(Stratagene). The titer of the cDNA library was 1.1U106 plaque-
forming units.
2.3. Isolation and nucleotide sequence analyses of clones encoding the
35 kDa and 19 kDa proteins
The Oplophorus cDNA library was screened by plaque hybridiza-
tion using synthetic oligonucleotide probes corresponding to the ami-
no-terminal sequences of the proteins (OL-3 for the 35 kDa protein
and SOL-2 for the 19 kDa protein; see Section 3.2) that were labeled
with T4 polynucleotide kinase and [Q-32P]ATP (3000 Ci/mmol) [16].
Thirty-¢ve thousand independent plaques (per 15 cm plate) were lifted
onto Biodyne A membrane ¢lters (1.2 Wm; Pall Corp., Port Wash-
ington, NY, USA), then cross-linked with a Stratagene UV cross-
linker. The ¢lters were hybridized with the labeled probes in a solu-
tion of 1.1 M NaCl/60 mM NaH2PO4, pH 7.4/6 mM EDTA/0.2%
Ficoll/0.2% SDS/0.02% salmon sperm DNA/0.2% bovine serum albu-
min at 50‡C for 16 h, washed three times in a solution of 300 mM
NaCl/30 mM sodium citrate at room temperature, and X-ray ¢lm
with an intensifying screen was then exposed with the ¢lters at
380‡C for 18 h. After isolating positive phage clones, the cDNA
inserts were excised as pBluescript phagemids [17], and nucleotide
sequence was determined using Applied Biosystems DNA sequencers
(models 373 and 377).
2.4. Western blot analysis
Highly puri¢ed native Oplophorus luciferase (80 Wg) emulsi¢ed with
Freund’s complete adjuvant (Calbiochem, La Jolla, CA, USA) was
used to immunize a female New Zealand White rabbit. Anti-Oplopho-
rus luciferase serum (500 dilution) was used for Western blot analysis
as previously described [18].
2.5. Homology search
A search of the non-redundant database of the National Center of
Biotechnology Information (NCBI) using the program Gapped Blast
[19] was performed. The molecular weight, isoelectric point (pI) and
hydrophobicity were calculated using DNASIS software Ver. 3.7 (Hi-
tachi Software Engineering, Yokohama, Japan).
2.6. Expression of cDNA for 35 kDa and 19 kDa proteins in
Escherichia coli and COS7 cells
The E. coli expression system for histidine-tagged 35 kDa and
19 kDa proteins was essentially as previously described [8]. For the
35 kDa protein, an XbaI/SalI fragment was obtained from pOL23 as
a template by polymerase chain reaction (PCR) ampli¢cation
(25 cycles; 1 min at 94‡C, 1 min at 50‡C, 1 min at 72‡C) using
Gene TaqNT polymerase (Nippon Gene, Toyama, Japan) with primer
sets of OL-7 (5P-CCGTCTAGA-GCT-GTT-GCC-TGT-CCT-GCA-
GCC-3P ; XbaI site underlined) and OL-8 (5P-GCCGTCGAC-TTA-
TTG-GCA-CAT-TGC-ATG-GAA-3P ; SalI site underlined). The frag-
ment was ligated with the NheI/XhoI site of pTrcHis-B (Invitrogen, La
Jolla, CA) to give the expression plasmid pHis-OL. For the 19 kDa
protein, an NheI/XhoI fragment from pKAZ-412, obtained by PCR
with KAZ-3 (5P-CCGGCTAGC-TTT-ACG-TTG-GCA-GAT-TTC-
GTT-GGA-3P ; NheI site underlined) and T7-BcaBEST (5P-TAATAC-
GACTCACTATAGGG-3P), was inserted into NheI/XhoI site of
pTrcHis-B to give the expression vector pHis-KAZ. The expressed
protein had an extra 14 amino acid residues at the N-terminus, which
included six histidine residues. The host strain used was BL21 (No-
vagen, Madison, WI, USA). Protein production was induced by the
addition of isopropyl-L-thio-galactopyranoside (¢nal concentration:
0.2 mM) at 37‡C in Luria^Bertani broth. After incubation of 3 h,
cells were harvested, then disrupted by sonication using a Branson
model 250 soni¢er (Danbury, CT, USA). After centrifugation at
12 000Ug for 10 min, the supernatant was used for the luminescence
assay.
For gene expression in COS7 cells, expression plasmids with and
without a putative signal peptide sequence were constructed from
pRL-cytomegalovirus (CMV) (Promega, Madison, WI) by replace-
ment of the NheI/XbaI region of the Renilla luciferase gene. NheI/
XbaI fragments derived from the coding sequence of 35 kDa and 19
kDa proteins was obtained by PCR and inserted into the NheI/XbaI
site of pRL-CMV. For the 35 kDa protein, pSOL-CMV was con-
structed by primer sets of OL-4 and OL-6, and pOL-CMV by primer
sets OL-5 and OL-6, where OL-4 is 5P-CCGGCTAGCCACC-ATG-
GCT-GTC-AAC-TTC-AAG-TTT-3P (NheI site underlined), OL-5
is 5P-CCGGCTAGCCACC-ATG-GCT-GTT-GCC-TGT-CCT-GCA-
GCC-3P, OL-6 is 5P-CCGCTCTAGAA-TTA-TTG-GCA-CAT-TGC-
ATG-GAA-3P (XbaI site underlined). For the 19 kDa protein,
pSKAZ-CMV was produced using primer sets of KAZ-1 and KAZ-
5, and pKAZ-CMV by primer sets of KAZ-2 and KAZ-5, where
KAZ-1 is 5P-CCGGCTAGCCACC-ATG-GCG-TAC-TCC-ACT-
CTG-TTC-ATA-3P, KAZ-2 is 5P-CCGGCTAGCCACC-ATG-TTT-
ACG-TTG-GCA-GAT-TTC-GTT-GGA-3P, and KAZ-5 is 5P-CC-
GCTCTA-GAA-TTA-GGC-AAG-AAT-GTT-CTC-GCA-AAG-CC-
T-3P.
COS7 cells (2U105) were grown in a 35 mm well plate containing
3 ml of Dulbecco’s modi¢ed Eagle’s medium (Gibco BRL, Rockville,
MD, USA) supplemented with 10% (v/v) heat-inactivated fetal calf
serum (Gibco BRL), 100 U/ml penicillin and 100 Wg/ml of streptomy-
cin. Cells were cultured at 37‡C under a humidi¢ed 5% CO2 atmos-
phere for 24 h, then transfected with 2 Wg of plasmid DNA using
FuGENE6 transfection reagent (Rosche Diagnostics, Mannheim,
Germany). After further incubation for 36 h, cultured medium and
cells were separated by centrifugation. The cells were suspended in
0.5 ml of phosphate-bu¡ered saline (Ca2 and Mg2 free), then stored
at 380‡C. Before assay, the cells were disrupted by three cycles of
freezing and thawing, and 2 Wl of the cell extracts and 10 Wl of the
culture media were used in the luminescence assay.
2.7. In vitro translation
In vitro transcription-coupled translation was carried out using a
TNT T7 Quick transcription/translation system with canine pancreatic
microsomal membranes (Promega) using pOL-CMV, pSOL-CMV,
pKAZ-CMV and pSKAZ-CMV. 25 Wl of reaction mixture containing
0.5 Wg of plasmid, 20 Wl of rabbit reticulocyte lysate, 1 Wl of 1 mM
methionine and 2.5 Wl of microsomal membranes was incubated at
30‡C for 90 min, then 1 Wl of the reaction mixture was assayed for
luminescence activity.
2.8. Assay for luminescence activity and measurement of emission
spectra
Coelenterazine and bisdeoxycoelenterazine were chemically synthe-
sized [8]. The total reaction mixture (100 Wl) contained coelenterazine
or bisdeoxycoelenterazine (1 Wg) in 50 mM Tris^HCl, pH 7.6, con-
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taining 10 mM EDTA. The reaction was started by the addition of a
test sample and the initial intensity of the luminescence was measured
by a Lab Science (Tokyo, Japan) model TD-4000 luminometer,
equipped with a Hamamatsu R-268 photomultiplier. The initial inten-
sity emitted by 1 Wg of native Oplophorus luciferase was 1.0U105 rlu
(relative luminescence unit; 1 rlu = 1.25U107 quanta/s).
Luminescence emission spectra were measured on a Hitachi model
F4010 £uorescence spectrophotometer at room temperature with the
excitation light source turned o¡.
2.9. Data deposition
The sequences reported in this paper have been deposited in the
DDBJ/EMBL/GenBank databases, with accession numbers AB030245
(35 kDa protein) and AB030246 (19 kDa protein).
3. Results and discussion
3.1. Two protein components of native Oplophorus luciferase
The molecular weight of highly active, puri¢ed native Oplo-
phorus luciferase was estimated to be about 106^000 by gel
¢ltration on a column of Superdex 200 (Fig. 1A). SDS^PAGE
analysis of the same luciferase gave two major protein bands
corresponding to molecular weights of 35 kDa and 19 kDa,
respectively, under both reducing and non-reducing condi-
tions (Fig. 1B). These two proteins were also obtained using
reversed phase HPLC. Thus, native Oplophorus luciferase is
considered to be a complex of 35 kDa and 19 kDa proteins,
bound together in a non-covalent manner. The molecular
weights and the estimated relative yields of the 35 kDa and
19 kDa proteins suggested that the luciferase is possibly com-
posed of two subunits each of the 35 kDa and 19 kDa pro-
teins.
3.2. cDNA cloning and nucleotide sequence analysis
3.2.1. 35 kDa protein. The amino-terminus of the 35 kDa
protein had the sequence Ala-Val-Ala-(Xaa)-Pro-Ala-Ala-
Glu-Asp-Ile-Ala-Pro-(Xaa)-Thr-(Xaa)-Lys-Val-Gly-Glu-Gly-
Asp-Val-Met-Asp-Met-Asp-(Xaa)-Ser-Lys-Val-Thr-Ser-Asp-
Ala-Glu-Leu-Ala-Ser-Phe (Xaa: amino acid not determined).
From the underlined sequence, a probe was designed for
screening: OL-3, 5P-GTN-GT(T/C)-GTN-ATG-GA(T/C)-
ATG-TC-3P, and nine positive clones were isolated from a
library of 70 000 independent clones using the plaque hybrid-
ization technique. Restriction enzyme analysis of all the clones
showed identical restriction maps; one clone, designated
pOL23, was subjected to DNA sequence analysis. The com-
plete DNA sequence and the deduced amino acid sequence for
pOL23 are shown in Fig. 2A. The open reading frame encodes
a protein of 359 amino acids. The experimentally determined
amino-terminus of the mature protein begins 39 amino acids
downstream, suggesting that the primary translation product
contains either an unusually long signal sequence, a propep-
tide, or both. However, we cannot exclude the possibility that
the sample of protein subjected to sequence analysis had
undergone some degradation at the amino-terminal end. The
amino acid sequences of the peptide fragments derived from
lysyl endopeptidase digestion were in agreement with those
deduced from the nucleotide sequence, including the amino
acid sequence at carboxy-terminus (underline in Fig. 2A).
Therefore, the 35 kDa protein should consist of 320 amino
acid residues, with a calculated molecular mass of 34 837.08
and an estimated pI value of 4.61.
3.2.2. 19 kDa protein. The amino-terminal sequence was
found to be Phe-Thr-Leu-Ala-Asp-Phe-Val-Gly-Asp-(Xaa)-
Gln-Gln-Thr-Ala-Gly-Tyr-Asn-Gln-Asp-Gln-Val-Leu-Glu-
Fig. 1. Determination of molecular weight of native Oplophorus lu-
ciferase. A: Molecular weight of native Oplophorus luciferase deter-
mined by Superdex 200 gel ¢ltration. The ¢lled circle represents
Oplophorus luciferase. The molecular weight markers (Pharmacia
Biotech) are as follows: a, amylase (200 000); b, alcohol dehydroge-
nase (150 000); c, bovine serum albumin (67 000); d, ovalbumin
(45 000); e, carbonic anhydrase (29 000); f, ribonuclease (13 700).
B: Western blot analysis of puri¢ed native Oplophorus luciferase on
SDS^PAGE gel using anti-Oplophorus luciferase antibody. The num-
bers on the left margin represent the molecular weights of the
marker (Pharmacia Biotech): phosphorylase b (94 000), bovine se-
rum albumin (67 000), ovalbumin (43 000), carbonic anhydrase
(30 000), soybean trypsin inhibitor (20 100) and K-lactalbumin
(14 400).
Table 1
In vitro translation of the 19 kDa and 35 kDa proteins using expression plasmids with and without a signal sequence, in the presence (+) and
absence (3) of microsomal membranes, at 30‡C for 90 min
Expression plasmid Expressed protein Microsomal membranes Luminescence activity (rlu)
pRL-CMV Renilla luciferase 3 3253.3
pOL-CMV 35 kDa 3 6 0.001
pSOL-CMV 35 kDa* 3 6 0.001
pSOL-CMV 35 kDa* + 6 0.001
pKAZ-CMV 19 kDa 3 1242.0
pSKAZ-CMV 19 kDa* 3 3.0
pSKAZ-CMV 19 kDa* + 65.0
pOL-CMV+pKAZ-CMV 35 kDa and 19 kDa 3 581.2
None None 3 6 0.001
The luminescence activities of the reaction mixtures were assayed using coelenterazine as the substrate. See Section 2 for the details of the ex-
pression plasmids. An asterisk indicates 35 kDa or 19 kDa protein with a signal sequence.
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Gln-Gly-Gly-Leu-Ser. The underlined sequence was used to
design the probe for screening, SOL-2: 5P-GCN-GGN-TA-
(T/C)-AA(T/C)-CA(A/G)-GA(T/C)-CA-3P. From 300 000 in-
dependent clones, one positive clone was isolated and the nu-
cleotide sequence was determined. This clone was designated
pKAZ-412. As shown in Fig. 2B, the 19 kDa protein con-
tained 196 amino acid residues including a putative signal
peptide sequence for secretion. Judging from the results of
the N-terminal sequence analysis of the protein, the mature
protein should consist of 169 amino acid residues with a cal-
culated molecular mass of 18 689.50 and a pI of 4.70.
As for the 35 kDa protein, it is not certain whether the
N-terminal extension represents a signal sequence, a propep-
tide, or both, and again the possibility of amino-terminal deg-
radation cannot be excluded.
3.3. In vitro translation of cDNAs
To identify the catalytic component involved in the lumi-
nescence reaction of Oplophorus luciferase, cDNAs encoding
the 35 kDa and 19 kDa proteins were expressed by means of
an in vitro transcription-translation system. Expression plas-
mids were constructed for the 35 kDa and 19 kDa proteins,
with and without a putative signal sequence at the N-termi-
nus, and used as the templates. As summarized in Table 1,
signi¢cant luminescence activity was found in the 19 kDa
protein expressed with pKAZ-CMV, but no activity was ob-
served in the 35 kDa protein expressed with pSOL-CMV or
pOL-CMV. These results indicate that the 19 kDa protein is
the catalytic component involved in the Oplophorus luciferase
reaction. The activity of the 19 kDa protein expressed with
the pSKAZ-CMV plasmid having a putative signal peptide
sequence was very weak. However, an increase of activity
was observed when canine pancreatic microsomal membranes
with the ability to cleave the signal peptide sequence were
included, indicating that the 19 kDa protein had contained
the signal peptide sequence. When both pOL-CMV (35
kDa) and pKAZ-CMV (19 kDa) were co-expressed in this
system, no enhancement of luminescence activity was ob-
served.
3.4. Heterologous expression of cDNAs in E. coli and COS7
cells
Expression plasmids for His-tagged 35 kDa and 19 kDa
proteins without the putative signal sequence were constructed
and expressed in E. coli. However, both proteins were ex-
pressed mainly as inclusion bodies (data not shown) and the
luminescence activity was detected only in the soluble fraction
from the pHis-KAZ expression. The amount of the active 19
kDa protein calculated on the basis of luminescence activity
was approximately 50 ng per ml of cell extracts. As shown in
Fig. 3, the luminescence spectrum measured with the crude
extract of recombinant His-tagged 19 kDa protein was in a
good agreement with that of native Oplophorus luciferase,
showing the light emission peak at about 455 nm.
For expression in mammalian cells (COS7), the plasmids
for the 35 kDa and 19 kDa proteins with and without putative
signal peptide sequence under the control of the CMV pro-
moter were transfected. The luminescence activities found in
the cell extracts and in the culture media are summarized in
Table 2. Activity was found only in the extracts of cells trans-
fected with plasmids encoding the 19 kDa protein. In the case
of the pSKAZ-CMV expression construct with the putative
signal sequence for secretion, the culture medium showed a
very low luminescence activity and no band corresponding to
the 19 kDa protein could be detected by Western blot analysis
using anti-Oplophorus antibodies (data not shown). These re-
sults suggest that either the putative signal sequence of the
Fig. 3. Bioluminescence spectra of His-tagged 19 kDa protein and
of native Oplophorus luciferase. Curve a: native Oplophorus lucifer-
ase (1 Wg); curve b: His-tagged 19 kDa recombinant protein ex-
tracted from 20 ml of culture, respectively with 1 Wg of coelenter-
azine in 500 Wl of 50 mM Tris^HCl, pH 7.6, containing 1 mM
EDTA.
Fig. 2. Nucleotide sequence and predicted amino acid sequence of
35 kDa and 19 kDa proteins derived from Oplophorus luciferase.
A: 35 kDa protein from pOL23. B: 19 kDa protein from pKAZ-
412. Underline indicates the region where the amino acid sequence
was identical with that obtained by lysyl endopeptidase digestion.
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Table 2
Expression of cDNA for 35 kDa and 19 kDa proteins in COS7 cells
Expression plasmid Luminescence activity (rlu)
Medium Cell extract
Substrate: Coelenterazine Coelenterazine Bisdeoxycoelenterazine
pRL-CMV 2.9 2059.5 2.6
pOL-CMV 2.5 6 0.001 6 0.001
pSOL-CMV 2.1 6 0.001 6 0.001
pKAZ-CMV 3.6 2273.0 2124.0
pSKAZ-CMV 1.9 297.5 217.0
None 1.9 6 0.001 6 0.001
The plasmids for expressing the 35 kDa and 19 kDa proteins, with and without a signal sequence, were transfected under the control of the
CMV promoter. The luminescence activities of the culture media and cell extracts were assayed using coelenterazine or bisdeoxycoelenterazine
as the substrate.
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19 kDa protein functioned poorly in COS7 cells, as was the
case in the in vitro translation system, or the secreted 19 kDa
protein was a¡ected by a degradative enzyme.
In the luminescence reaction with the 19 kDa protein, both
coelenterazine and bisdeoxycoelenterazine were highly e⁄cient
substrates, in agreement with the substrate speci¢city of native
Oplophorus luciferase previously reported [8]; this fact may
suggest that the function of the 35 kDa protein in the lucif-
erase is unrelated to substrate speci¢city. When the 19 kDa
protein was expressed in COS7 cells using pKAZ-CMV, the
activity of cell extracts was high, exceeding that of Renilla
luciferase expressed with pRL-CMV (Table 2). This suggests
that the 19 kDa protein may be a good candidate for use as a
new reporter protein in mammalian cell systems.
3.5. Structure and function of the 35 kDa and 19 kDa proteins
As shown in Fig. 4A, the 35 kDa protein contains leucine-
rich repeat sequences with the consensus sequence (Leu/Ile)-
Xaa-Xaa-Leu-Xaa-(Leu/Ile)-Xaa-Xaa-Asn-Xaa-(Leu/Ile)-Xa-
a-Xaa-Xaa-Pro (Xaa: any amino acid residue), which is com-
mon in many members of the leucine-rich repeat family
[20,21]. A homology search of the deduced amino acid se-
quence using the gapped Blast program revealed a high sim-
ilarity between the 35 kDa protein and chaoptin, a photo-
receptor cell-speci¢c membrane adhesion protein [22]; the
calculation gave an E value (homology score) of 8U1039
and showed that 25% of amino acids are identical. The
35 kDa protein contains 11 cysteine residues, but there is no
potential N-linked glycosylation site with a canonical se-
quence of Asn-Xaa-(Ser/Thr).
In an e¡ort to clarify the interaction between the 35 kDa
and 19 kDa proteins, native luciferase was treated with vari-
ous detergents and denaturants. Nevertheless, the 35 kDa and
19 kDa proteins formed, as well as the mixture of them, were
all found to be inactive in catalyzing the luminescence of
coelenterazine, and no catalytic activity could be restored
under various conditions tested (data not shown). Thus, the
function of the 35 kDa protein remains unknown, although
the protein may have a role in the stabilization of the 19 kDa
protein.
The 19 kDa protein of Oplophorus luciferase is the smallest
catalytic component having the luciferase function presently
known [23] and its primary structure has no signi¢cant ho-
mology with any reported luciferase including imidazopyrazi-
none luciferases [24,25]. The overall amino acid sequence of
the 19 kDa protein appears similar to that of E. coli amine
oxidase (757 amino acid residues; pir 140924) in the region of
residues 217^392 (domain of D3^S1) [26], as shown in Fig.
4B, whereas the amino-terminal region (3^49) of the same
protein is homologous to the amino-terminal region (1^47)
of a fatty acid binding protein (132 amino acid residues;
GenBank, L23322) [27] (data not shown). However, it is di⁄-
cult to rationalize the relationship between the functions and
the structural similarities in these examples at present.
Previously, the primary structures were determined for sev-
eral enzymes and proteins that are functional with an imid-
Fig. 4. Structures of the 35 kDa and 19 kDa proteins. A: Alignment of the leucine-rich repeats of 35 kDa protein. The leucine-rich repeats in
35 kDa protein are shown aligned with one another. The criterion for the consensus sequence is that the respective amino acid be present in at
least 40% of the cases. The amino acid sequence location is shown on the left. B: Sequence homology between (a) 19 kDa protein and
(b) amine oxidase (pir 140924). The double dots indicates identical residues and the single dots indicate amino acids with homologous scores in
the Dayho¡ mutation data matrix [33]. Numbers indicate the position from the N-terminus of each protein.
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azopyrazinone compound, including Renilla luciferase
(36 kDa) [24], aequorin (21.5 kDa) [28], Renilla luciferin bind-
ing protein (20.5 kDa) [29] and Cypridina luciferase (58.5 kDa)
[25]. Among these proteins, Renilla luciferase (GenBank,
M63501) is structurally similar to haloalkane dehalogenase
(GenBank, M26950) [30] ; aequorin (GenBank, L29571) and
Renilla luciferin binding protein (SwissProt, P05938) are sim-
ilar to EF hand-type calcium binding proteins such as calmod-
ulin [31] ; and Cypridina luciferase (GenBank, M25666) is sim-
ilar to the von Willebrand factor precursor (GenBank,
X04146) [32]. Although the relationship between the structur-
al similarities and the functions of the catalytic domain re-
mains unclear, it is intriguing and possibly signi¢cant to ¢nd
no apparent similarity between the primary structures of
Oplophorus luciferase and Renilla luciferase despite the fact
that both luciferases catalyze the oxidation of coelenterazine
to emit blue light.
Acknowledgements: We thank Mr. T. Hanai of Shizuoka Prefectural
Fisheries Experiment Station and Dr. Y. Shizuri of Marine Biotech-
nology Institute for assistance in the collection of Oplophorus. This
work was supported in part by a grant from the National Science
Foundation (MCB-9722982) to O.S.
References
[1] Harvey, E.N. (1952) in: Bioluminescence, pp. 345^354, Academic
Press, New York.
[2] Johnson, F.H., Stachel, H.-D., Shimomura, O. and Haneda, Y.
(1966) in: Bioluminescence in Progress (Johnson, F.H. and Ha-
neda, Y., Eds.), pp. 523^532, Princeton University Press, Prince-
ton, NJ.
[3] Shimomura, O., Masugi, T., Johnson, F.H. and Haneda, Y.
(1978) Biochemistry 17, 994^998.
[4] Herring, P.J. (1976) J. Mar. Biol. Assoc. UK 56, 1029^1067.
[5] Inoue, S., Kakoi, H., Murata, M., Goto, T. and Shimomura, O.
(1977) Tetrahedron Lett. 31, 2685^2688.
[6] Shimomura, O. and Johnson, F.H. (1975) Nature 256, 236^238.
[7] Head, J.F., Inouye, S., Teranishi, K. and Shimomura, O. (2000)
Nature 405, 372^376.
[8] Inouye, S. and Shimomura, O. (1997) Biochem. Biophys. Res.
Commun. 233, 349^353.
[9] Nakamura, H., Wu, C., Murai, A., Inouye, S. and Shimomura,
O. (1997) Tetrahedron Lett. 38, 6405^6406.
[10] Johnson, F.H. and Shimomura, O. (1978) Methods Enzymol. 57,
331^364.
[11] Laemmli, U.K. (1970) Nature 227, 680^685.
[12] Towbin, H., Staehelin, T. and Gordon, J. (1977) Proc. Natl.
Acad. Sci. USA 76, 4350^4354.
[13] Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter,
W.J. (1979) Biochemistry 18, 5294^5299.
[14] Inouye, S. and Tsuji, F.I. (1993) FEBS Lett. 315, 242^246.
[15] Kakizuka, A., Yu, R., Evans, R.M. and Umesono, K. (1993) in:
Essential Developmental Biology (Stern, C.D., Ed.), pp. 223^232,
IRL Press, Oxford.
[16] Wallace, R.B., Johnson, M.J., Hirose, T., Miyake, T., Kawashi-
ma, E.H. and Itakura, K. (1981) Nucleic Acids Res. 9, 879^897.
[17] Short, M.J., Fernandez, M.J., Sorge, J.A. and Huse, W.D. (1988)
Nucleic Acids Res. 16, 7583^7600.
[18] Inouye, S. and Tsuji, F.I. (1992) Anal. Biochem. 201, 114^118.
[19] Altschul, S.F., Madden, T.L., Scha¡er, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Nucleic Acids Res. 25,
3389^3402.
[20] Kobe, B. and Deisenhofer, J. (1994) Trends Biochem. Sci. 19,
415^421.
[21] Buchanan, S.G.St.C. and Gay, N.J. (1996) Prog. Biophys. Mol.
Biol. 65, 1^44.
[22] Reinke, R., Krantz, D.E., Yen, D. and Zipursky, S.L. (1988) Cell
52, 291^301.
[23] Wilson, T. and Hastings, J.W. (1998) Annu. Rev. Cell Dev. Biol.
14, 197^230.
[24] Lorenz, W.W., McCann, R.O., Longiaru, M. and Cormier, M.J.
(1991) Proc. Natl. Acad. Sci. USA 88, 4438^4442.
[25] Thompson, E.M., Nagata, S. and Tsuji, F.I. (1989) Proc. Natl.
Acad. Sci. USA 86, 6567^6571.
[26] Parson, M.R., Convery, M.A., Wilmot, C.M., Yadav, K.D.S.,
Blakeley, V., Corner, A.S., Phillips, S.E.V., McPherson, M.J.
and Knowles, P.F. (1995) Structure 3, 1171^1184.
[27] Becker, M.M., Kalinna, B.H., Waine, G.J. and McManus, D.P.
(1994) Gene 148, 321^325.
[28] Inouye, S., Noguchi, M., Sakaki, Y., Takagi, Y., Miyata, T.,
Iwanaga, S., Miyata, T. and Tsuji, F.I. (1985) Proc. Natl.
Acad. Sci. USA 82, 3154^3158.
[29] Kumar, S., Walsh, K.A., Cormier, M.J. and Charbonneau, H.
(1990) FEBS Lett. 268, 287^290.
[30] Janssen, D.B., Pries, F., Proeg, J., Kazemier, B., Terpstra, P. and
Witholt, B. (1989) J. Bacteriol. 171, 6791^6799.
[31] Tsuji, F.I., Ohmiya, Y., Fagan, F.T., Toh, H. and Inouye, S.
(1995) Photochem. Photobiol. 62, 657^661.
[32] Verweij, C.L., Diergaarde, P.J., Hart, M. and Pannekoek, H.
(1986) EMBO J. 5, 1839^1847.
[33] Dayho¡, M.O., Schwartz, R.M. and Orcutt, B.C. (1978) in: At-
las of Protein Sequence and Structure, Vol. 5, pp. 345^352, Na-
tional Biomedical Research Foundation, Washington, DC.
FEBS 24076 1-9-00
S. Inouye et al./FEBS Letters 481 (2000) 19^25 25
